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Abstract
Measurement of erythrocyte aging parameters in patients with dementia indicates that ail 
Alzheimer-related disturbance of the erythrocyte aging process may not be detectable until in 
the more advanced stages of the disease. Also, a strong fluctuation in the values of 
erythrocyte aging parameters, over a period of 15 months, was observed in patients with 
dementia, but not in age-matched control donors. This fluctuation was independent of the 
type and stage of dementia, and its cause remains to be elucidated. Such variability hampers 
the use of erythrocyte aging characteristics for the diagnosis of dementia. On the other hand, 
the aging-related erythrocyte IgG content may be a sensitive biomarker for disturbed 
systemic homeostasis in the elderly. © 1998 Elsevier Science Ireland Ltd.
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1- Introduction
Recent findings support the theory that processes leading to disturbed cellular 
aging and untimely cell death are part of the etiology of Alzheimer’s disease (AD; 
Bosman and De Grip, 1996). In AD, a disturbance of the normal cellular aging 
process may not be restricted to the brain (Zatta and Nicolini, 1995). Structural and 
functional changes in the anion exchanger (band 3 or AE1) are central in the aging 
process of the human erythrocyte (Kay, 1993), and indications have been found for 
a disturbance of erythrocyte aging in patients in advanced stages of AD (Bosman 
et al., 1991). Subsequent studies in individuals with Down’s syndrome indicated 
that some erythrocyte aging parameters become abnormal in a presymptomatic 
stage (Bosman et al., 1993). In order to substantiate this conclusion, the following 
questions were addressed: (1) Do the erythrocyte band 3-related aging characteris­
tics constitute a stable trait in healthy humans, or do they vary with age? (2) Are 
erythrocyte aging parameters affected by the stage of the disease in AD patients?
In view of the putative importance of this issue for early diagnosis, we repeatedly 
measured erythrocyte aging characteristics in patients with various types and in 
various stages of dementia in a period of 15 months after their admittance to a 
psychogeriatric nursing home. All patients (N = 35; 8 1 + 5  years old) had a general 
diagnosis of dementia, with a Global Deterioration Scale (GDS) of 5 or more 
(Reisberg et a l, 1982). Using the diagnostic criteria described previously (Bosman 
et al., 1991), patients were divided into four groups: senile dementia of the 
Alzheimer Type (SDAT), dementia of vascular origin (VASC), mixed type dementia 
(MIX), and atypical dementia (ATY). Mixed type dementia was defined when a 
vascular origin was suspected (e.g. hypodensity of vascular origin on CT scan, or a 
hypoperfusive incident), but with insidious onset, and atypical dementia was 
diagnosed when a clear choice between SDAT, VASC, and MIX could not be made 
(Koopmans, 1994). All groups were matched with respect to age, GDS, duration 
and stage of the disease, and use of medicine. During the course of this study, 
dementia progressed to a similar extent in the various groups, as indicated by an 
increase in the mean GDS scores of one to two. Control groups consisted of 
age-matched (AMC; N=10;  85 ±  5 years old) and young (YC; N ~  8; 31 ± 4  years 
old) healthy donors. Diagnosis was performed by one of us (PvdL), who had no 
access to the biochemical data. Blood samples (five ml) were collected at least three 
times in a period of 15 months. Cell separation, measurement of erythrocyte-bound 
IgG, determination of anion transport characteristics, and immunoblot analysis of 
erythrocyte AE1 were performed in batches of eight individuals as described before 
(Bosman et al., 1991, 1993).
2. Materials and methods
2.1. Erythrocyte-bound Immunoglobulin G
The mean IgG values of all patient groups and of the age-matched, elderly 
control group were significantly higher than that of the young control donors
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(Table 1), confirming a previous observation that the erythrocyte IgG content is 
increased in the elderly (Bosman et a l, 1993). At the start of the study, the mean 
erythrocyte-bound IgG values of the patient groups did not differ significantly 
between the groups, or between any of the patient groups and the age-matched 
controls (Table 1). After approximately 15 months after admission, however, the 
mean erythrocyte IgG content significantly increased in the groups with vascular 
dementia and mixed type dementia relative to the control groups (Table 1).
In contrast to the age-matched and young control groups, all patient groups showed 
a considerable individual variation in erythrocyte IgG content with time (Fig. 1). The 
percentage of individuals showing an arbitrary difference of 1.0 fgm/1000 erythrocytes 
between two subsequent measurements among the patients with a vascular compo­
nent is twice that found in the other patient groups (80 and 75% in the VASC and 
MIX group, respectively, versus 40% in the SDAT group). There were no significant 
differences in the mean values of the slopes of the regression lines of the IgG values 
between the patient groups. However, in the SDAT group 55% of the patients had 
a negative slope, whereas in the vascular and mixed type dementia group the majority 
of the patients (65 and 75%, respectively) bad a positive slope. There was no significant 
correlation between individual IgG values and GDS scores.
3. Anion transport characteristics
The mean values of the anion transport characteristics Km and Fmax (Bosman et 
al., 1991) were not significantly different from previous measurements, nor did they 
differ significantly between the various groups. However, they showed the same strong 
longitudinal variation as observed for the IgG concentrations. A negative correlation 
was observed between the values of IgG and of the Vmax of sulfate exchange, in 
agreement with previous findings (data not shown; Bosman et al., 1993).
Table 1
Erythrocyte-bound IgG values of the various patient and control groups at various periods after 
admission to a psychogeríatric nursing home or the start of the study, respectively1'
3 months 9 months 15 months
YC 0.7 ±0.1 0.8 ±0.1 0,8 ± 0 .3
AMC 1.4 ± 0 .2 1.4 ± 0 .4 1.8 ± 0 .3
SDAT 2.7 ±1 .7 2.7 ±  0.7 2.8 ± 2 .4
ATY 2.1 ±0 .7 2.4 ±  1.3 2.0 ± 0 .9
VASC 3.3 ±2 .7 2.9 ± 0 .6 4.0 ±2.0*
MIX 2.4 ±0 .9 3.0 ± 2 .0 5.5 ±2.3*
“ The amount of erythrocyte-bound IgG was measured as described before (Bosman et al,, 1991), and is 
expressed in fgm/1000 erythrocytes. YC, young controls (N — 6)\ AMC, age-matched controls (TV =  10); 
SDAT, senile dementia of the Alzheimer type (JV= 14); VASC, vascular dementia ( N =  9); MIX, mixed 
type dementia (N — 5); ATY, atypical dementia ( N — 7). See the Section 2 for diagnosis and description 
of the donor groups. The mean group values were compared using ‘one way analysis of variance’, and 
values were considered signficantly different (*) from the AMC and YC values when P <0.05.
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Fig. 1. Erythrocyte-bound IgG of individual donors as a function o f time. For abbreviations see the 
legend to Table 1.
4. Band 3 immunoblotting analysis
Immunoblot analysis of erythrocyte membranes with most anti-band 3 antisera 
shows, in addition to the major band 3 protein of 95 kDa, multiple smaller 
immunoreactive polypeptides (Fig. 2), that are probably breakdown products of 
band 3 (Kay, 1993). In SDAT patients fragmentation was already obvious at the
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start of the study (Lane la), without a notable increase after one year (Lane lb), 
whereas in most VASC patients fragmentation increases with time (Lane 2a, blood 
collected at the start of the study, with Lane 2b, blood collected 1 year later). Such 
an increase with time was not detectable in samples from age-matched control 
donors (Lanes 3a and 3b). The immunoblot of the MIX patients’ erythrocytes show 
band 3 patterns that are similar to those of the SDAT patients (Lanes 4a and 4b). 
Quantification of the band 3 breakdown products did not show a significant 
correlation between their relative amounts and any of the other aging-related 
parameters.
The results of this study confirm previous conclusions that erythrocyte membrane 
characteristics indicate a disturbance of the erythrocyte aging process in patients 
with dementia (Bosman et al, 1991, 1993). These previous data, however, were 
obtained in patients that were in a more advanced stage of the disease, had a longer 
duration of the disease, and had been studied much longer after their admittance to 
the psychogeriatric institution than the patients described here (Bosman et ah, 
1991). This comparison suggests that an increase in erythrocyte IgG content and 
changes in anion transport characteristics are not specific for Alzheimer-type 
dementia, and that they are only observed in advanced disease stages. Band 3 
breakdown, however, is already significantly increased in patients with beginning 
stages of Alzheimer-type dementia, as was indicated by data obtained in individuals 
with Down’s syndrome (Bosnian et al., 1993). A detailed immunochemical and 
structural analysis of the breakdown products should provide the means to further 
investigate this issue.
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Fig. 2. Immunoblot analysis of band 3 fragmentation in erythrocyte membranes o f patients with 
dementia, Section 1, SDAT; Section 2, VASC, Section 3, AMC; Section 4, MIX. Lanes a and b, 
erythrocytes collected at 3 and 15 months after admission to the psychogeriatric institution, or the start 
of the study (for AMC), respectively. For abbreviations see the legend to Table 1.
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A complicating factor, reported here for the first time, is the variation with time 
in the erythrocyte aging characteristics of the demented elderly. None of the 
patients and control donors had any observable or measurable symptoms of 
physical illness at the times their blood samples were taken. This variation is 
therefore probably caused by variations in erythrocyte genesis and/or removal 
since, in the elderly, erythrocyte homeostasis is easily disturbed by subclinical 
stressors (Rothstein, 1993). This is supported by the observation that the erythro­
cyte IgG content increases with time especially in those patients with vascular 
dementia (VASC and MIX). These patients have more comorbidity, especially of 
cardiovascular nature, and a shorter life expectancy than SDAT patients (Koop- 
mans, 1994; Wolf-Klein et a l, 1988). Erythrocyte aging-related parameters such as 
erythrocyte IgG content may thus be sensitive biomarkers for disturbed systemic 
homeostasis in the elderly.
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